Carboprost Tromethamine Market to Gain 2.96 Billion, by 2033 with 4% CAGR: States The Brainy Insights [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
The market will experience rapid growth due to the increasing healthcare infrastructure investment during the forecast period. Newark, April 29, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 2 billion in 2023 global carboprost tromethamine market will reach USD 2.96 billion in 2033. The main applications for carboprost tromethamine are in gynaecology and obstetrics. It stimulates uterine contractions in a manner akin to that of naturally occurring prostaglandins and is delivered via injection. Its primary uses are in labour induction, postpartum haemorrhage control, and abortion induction. In obstetric and gynecologic practice, carboprost tromethamine is used when it's necessary to promote labour, manage postpartum haemorrhage, or induce abortion. In some situations, carboprost tromethamine offers a safer, non-surgical approach for inducing abortions. Download Report Sample (230+ Pages PDF with Insights) at: https://www.thebrainyinsights.com/enquiry/sample-re
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- 2 Top Growth Stocks Down 24% and 50% to Buy With $100 [Yahoo! Finance]Yahoo! Finance
- Migraine Nasal Spray Market Forecast to Reach $621.6 Million by 2030: Global Analysis by Formulation, Packaging, Dosage, Distribution Channel, and Region [Yahoo! Finance]Yahoo! Finance
- The New Menopause: Dr Mary Claire Haver On Shame And Stigma Free Aging [Forbes]Forbes
- Global Vertigo Treatment Market Forecast to Reach $1.6 Billion by 2030, Driven by the Rise in Benign Paroxysmal Positional Vertigo Prevalence [Yahoo! Finance]Yahoo! Finance
- FirstFT: Investors pull money from Starwood $10bn property fund [FT.com - Mergermarket]FT.com - Mergermarket
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/9/24 - Form S-8
- PFE's page on the SEC website